Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,754 evidence items · page 9 / 71

73.3 %Sensitivity for the detection of all stages of diabetic retinopathy using the smartphone-based retinal camera was 73.3%.

Cameroundiabetic retinopathypublished 2019Ophthalmic surgery, lasers & imaging retinaeurope_pmcdocument of 16 observations

1.1 %The age-adjusted prevalence of undiagnosed type 2 diabetes in Cameroon was 1.1%.

Cameroundiabète de type 2published 2011The British journal of nutritioneurope_pmcdocument of 5 observationsDOI 10.1017/s0007114510003399

7.1 %Enterococcus spp. accounted for 7.1% of isolated germs.

Camerounpied diabétiquepublished 2022The Pan African medical journaleurope_pmcdocument of 25 observations

28.7 %The prevalence of hypertension was 28.7% among women in the rural Fulani population of Cameroon aged ≥ 20 years.

Camerounhypertension artérielleobserved 2013published 2017Journal of health, population, and nutritioneurope_pmcdocument of 3 observationsDOI 10.1186/s41043-017-0112-2

88 patientsA cohort of patients of sub-Saharan African origin included 88 patients with type 2 diabetes.

Cameroundiabète de type 2published 2004Diabeteseurope_pmcdocument of 8 observationsDOI 10.2337/diabetes.53.3.645

29 %Cerebral toxoplasmosis was associated with inpatient mortality of 29% in a small cross-sectional study from Cameroon.

Camerouncerebral toxoplasmosisHAL · Unilimdocument of 205 observations

16.4 %The prevalence of Cornell product left ventricular hypertrophy among type 2 diabetes patients in Cameroon was 16.4%.

CamerounCornell product left ventricular hypertrophy · diabète de type 2published 2012Cardiovascular journal of Africaeurope_pmcdocument of 11 observations

6.5 mmol/LThe optimal cut-point to diagnose NICE-diagnosed GDM was 6.5 mmol/L for random plasma glucose (RPG) with a c-statistic of 0.61.

Cameroundiabète gestationnelpublished 2023Frontiers in clinical diabetes and healthcareeurope_pmcdocument of 9 observationsDOI 10.3389/fcdhc.2023.1272333

1,300,000 casesIn 2017, there were 1.3 million incident cases of prostate cancer in men.

Camerouncancer de la prostateobserved 2017published 2019JAMA oncologyeurope_pmcdocument of 25 observationsDOI 10.1001/jamaoncol.2019.2996

4 %The prevalence of the 233F/V substitution in protease sequences was 4% (2/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublished 2011AIDS Research and Human RetrovirusesOpenAlexdocument of 24 observations

51.3 %Overall age-standardized SARS-CoV-2 IgG seroprevalence in Yaoundé, Cameroon was 51.3% during April 24–May 19, 2021.

CamerounCOVID-19observed April 24–May 19, 2021published 2022Emerging infectious diseasesOpenAlexdocument of 2 observationsDOI 10.3201/eid2806.212580

99 %Ninety-nine percent of patients had type 2 diabetes.

Cameroundiabète de type 2published 2022The Pan African medical journaleurope_pmcdocument of 25 observations

15.9 nmol/LMean serum folate was 15.9 nmol/L.

Camerouncardiometabolic diseasepublished 2021Current developments in nutritioneurope_pmcdocument of 6 observations

32.1 %In 2019, 32.1% of all adolescent deaths were due to communicable, nutritional, or maternal causes.

Camerouncommunicable, nutritional, or maternal causesobserved 2019published 2021Lancet (London, England)europe_pmcdocument of 13 observations

30 %Prevalence of obesity was more than 30% in boys in the Cook Islands, Nauru, Palau, Niue, and American Samoa in 2016.

Camerounobésitéobserved 2016published 2017Lancet (London, England)europe_pmcdocument of 12 observations

50 %LLINs from both Bertoua and Eyang failed to reach the 50% mortality threshold required for minimal effectiveness against field-collected Anopheles strains.

CamerounpaludismeHAL · Unilimdocument of 89 observations

0.94 p_valueThere was no difference between baseline and repeated G6PD activity levels during acute hyperglycaemia in ketosis-prone type 2 diabetes patients (P=0.94).

Cameroundiabète de type 2published 2015Diabetes & metabolismeurope_pmcdocument of 4 observations

876 casesThere were 876 malaria cases among 1480 individuals in Mfou.

CamerounpaludismeHAL · Unilimdocument of 106 observations

33 patientsThe study included 33 insulin-resistant HIV-infected patients.

Camerouninsulin resistance · VIH/sidapublished 2011Nutrientseurope_pmcdocument of 5 observationsDOI 10.3390/nu3070712

52 %The incidence of drug-induced hepatotoxicity (DIH) was 52% among HIV patients in Cameroon.

Cameroundrug-induced hepatotoxicity · VIH/sidaobserved 2018-2019published 2024BMC infectious diseaseseurope_pmcdocument of 4 observations

28 %According to the National Malaria Control Programme (NMCP) report, approximately 28% of hospital morbidity was due to malaria in 2019.

Camerounpaludismeobserved 2019HAL · Unilimdocument of 106 observations

57.29 %The frequency of multiclonal infections was higher in Tibati (57.29%) than in Mfou (68.9%).

CamerounpaludismeHAL · Unilimdocument of 106 observations

17.7 %GDM prevalence was 17.7% using IADPSG 2010 criteria in a Cameroonian population.

Cameroundiabète gestationnelpublished 2023Frontiers in clinical diabetes and healthcareeurope_pmcdocument of 9 observationsDOI 10.3389/fcdhc.2023.1272333

No symptomatic arrhythmic events occurred during the treatment course.

CamerounCOVID-19observed 2020published 2020Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as aeurope_pmcdocument of 6 observationsDOI 10.1101/2020.06.24.20139386

7 %Among adults tested for HIV during the campaign, 588 (7%) tested HIV-positive.

CamerounVIH/sidapublished 2012Journal of the International AIDS Societyeurope_pmcdocument of 39 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.